Search research articles
Contact Us
Filters
Showing results (301-310 of 347) with videos related to
Page
of 35
Sort By:
American Journal of Hematology
|
January 11, 2020
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
Ho Sup Lee, Kihyun Kim, Seok Jin Kim, et al.
Oncotarget
|
October 31, 2015
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome
Seong Hyun Jeong, Yoo-Jin Kim, Je-Hwan Lee, et al.
International Journal of Antimicrobial Agents
|
May 29, 2016
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
Wan Beom Park, Joo-Youn Cho, Sang-In Park, et al.
The Lancet. Oncology
|
November 1, 2020
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
Shaji K Kumar, Simon J Harrison, Michele Cavo, et al.
Annals of Hematology
|
January 17, 2017
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience
Shin Hye Yoo, Youngil Koh, Dae-Young Kim, et al.
The New England Journal of Medicine
|
September 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
Daniel Wolff, Corey Cutler, Stephanie J Lee, et al.
Nature
|
July 24, 2024
Blood culture-free ultra-rapid antimicrobial susceptibility testing
Tae Hyun Kim, Junwon Kang, Haewook Jang, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2018
The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension
Hyeon Jeong Suh, Seo Hyun Yoon, Kyung-Sang Yu, et al.
Leukemia Research
|
May 21, 2014
Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG
Hawk Kim, Kyoo-Hyung Lee, Inho Kim, et al.
Blood
|
December 15, 2025
Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial
Jorge E Cortes, Timothy P Hughes, Jianxiang Wang, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 347) with videos related to
Sort By:
Page
of 35
American Journal of Hematology
|
January 11, 2020
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
Ho Sup Lee, Kihyun Kim, Seok Jin Kim, et al.
Oncotarget
|
October 31, 2015
A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome
Seong Hyun Jeong, Yoo-Jin Kim, Je-Hwan Lee, et al.
International Journal of Antimicrobial Agents
|
May 29, 2016
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
Wan Beom Park, Joo-Youn Cho, Sang-In Park, et al.
The Lancet. Oncology
|
November 1, 2020
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
Shaji K Kumar, Simon J Harrison, Michele Cavo, et al.
Annals of Hematology
|
January 17, 2017
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience
Shin Hye Yoo, Youngil Koh, Dae-Young Kim, et al.
The New England Journal of Medicine
|
September 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
Daniel Wolff, Corey Cutler, Stephanie J Lee, et al.
Nature
|
July 24, 2024
Blood culture-free ultra-rapid antimicrobial susceptibility testing
Tae Hyun Kim, Junwon Kang, Haewook Jang, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2018
The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension
Hyeon Jeong Suh, Seo Hyun Yoon, Kyung-Sang Yu, et al.
Leukemia Research
|
May 21, 2014
Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG
Hawk Kim, Kyoo-Hyung Lee, Inho Kim, et al.
Blood
|
December 15, 2025
Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial
Jorge E Cortes, Timothy P Hughes, Jianxiang Wang, et al.
Page
of 35